Sudden Sensorineural Hearing Loss in Wonju Severance Christian Hospital
Launched by WONJU SEVERANCE CHRISTIAN HOSPITAL · Jul 24, 2022
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying sudden sensorineural hearing loss (SSNHL), a condition where people experience a rapid loss of hearing that can happen without warning. The trial is taking place at Wonju Severance Christian Hospital and aims to track how well patients recover from this type of hearing loss. Patients will be evaluated based on their hearing tests and medical history, and those who qualify will receive different treatments, including a combination of medications and therapies designed to help improve their hearing.
To be eligible for this study, participants must be adults over 20 years old who have been diagnosed with sudden hearing loss that meets specific criteria. This means their hearing loss must be at least 30 decibels (a measure of hearing ability) and occurred within three days. Participants will be asked to give their written consent after understanding the purpose of the study. If you or someone you know is dealing with sudden hearing loss, this trial offers a chance to contribute to important research while potentially receiving helpful treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients over 20 years of age
- • A patient who visited Wonju Severance Christian Hospital, Department of Otolaryngology and was diagnosed with sudden hearing loss as it was confirmed that hearing loss of 30dBHL or more occurred within 3 days at three consecutive frequencies in a pure tone audiometry test.
- • Those who have fully explained the purpose and content of the study and voluntarily agreed to the written consent
- Exclusion Criteria:
- • If the patients do not want to or do not fill out the consent form
- • If treatment is started for sudden hearing loss, but the possibility of other inner ear diseases including Meniere's disease is suspected due to repeated hearing loss, repeated recovery, dizziness, tinnitus, etc.
- • Other cases where it is judged difficult to carry out the clinical trial due to the judgment of the person in charge of the above clinical trial
About Wonju Severance Christian Hospital
Wonju Severance Christian Hospital is a leading healthcare institution based in South Korea, renowned for its commitment to innovative medical research and high-quality patient care. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical knowledge through rigorous scientific studies and trials across various therapeutic areas. With a multidisciplinary team of experienced researchers and healthcare professionals, Wonju Severance Christian Hospital strives to improve treatment outcomes and enhance the overall health and well-being of patients. Its state-of-the-art facilities and adherence to ethical standards ensure a robust framework for conducting clinical research that meets both local and international regulatory requirements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wŏnju, Gangwon, Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials